Is tolvaptan successful in treating inappropriate antidiuretic hormone secretion in infants?
Tolvaptan provided effective treatment for SIADH in both infants and could be administered orally.
Additional common variants in the APOL1-APOL4-MYH9 region do not contribute significantly to ESKD risk beyond the APOL1 G1 and G2 alleles.